Literature DB >> 26655704

Composition and stability of intestinal microbiota of healthy children within a Dutch population.

Tim G J de Meij1,2, Andries E Budding3, Evelien F J de Groot1, Fenna M Jansen1, C M Frank Kneepkens1, Marc A Benninga4, John Penders5, Adriaan A van Bodegraven6,7, Paul H M Savelkoul3,5.   

Abstract

Numerous diseases linked to microbial imbalance can be traced back to childhood, illustrating the impact of the juvenile microbiota development from infancy toward adulthood. However, knowledge on this subject is currently very limited. The primary aim of this study was to characterize composition and short- and long-term stability of the intestinal microbiota in healthy children. Between November 2011 and June 2014, 61 children 2 to 18 yr of age from different areas in The Netherlands were included and instructed to collect fecal samples weekly, for 6 wk, and a follow-up sample after 18 mo. The intergenic spacer profiling technique (IS-pro) was used to analyze all available fecal samples. Microbial diversity was calculated by the Shannon diversity index and individual compositional stability by comparing all collection time points. Microbial stability varied per phylum (P< 0.0005), declined rapidly in a short time period, and subsequently stabilized on the long run with very gradual variation, leading to an overall compositional stability of 70% on average over a period of 18 mo. Higher species diversity was correlated to a higher overall compositional stability (P< 0.001). We observed an age-independent bacterial shared core consisting of a limited number of species. In conclusion, in this study, we showed that microbial composition stability in children varied per phylum, at both short-term and long-term intervals. Healthy children seem to share a microbiome core consisting of a limited number of species.-De Meij, T. G. J., Budding, A. E., de Groot, E. F. J., Jansen, F. M., Kneepkens, C. M. F., Benninga, M. A., Penders, J., van Bodegraven, A. A., Savelkoul, P. H. M. Composition and stability of intestinal microbiota of healthy children within a Dutch population. © FASEB.

Entities:  

Keywords:  454-pyrosequencing; IS-pro; core; diversity; microbiome

Mesh:

Substances:

Year:  2015        PMID: 26655704     DOI: 10.1096/fj.15-278622

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

2.  Explainable artificial intelligence models using real-world electronic health record data: a systematic scoping review.

Authors:  Seyedeh Neelufar Payrovnaziri; Zhaoyi Chen; Pablo Rengifo-Moreno; Tim Miller; Jiang Bian; Jonathan H Chen; Xiuwen Liu; Zhe He
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

3.  Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease.

Authors:  A Eck; E F J de Groot; T G J de Meij; M Welling; P H M Savelkoul; A E Budding
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

4.  Infant Gut Microbiome Associated With Cognitive Development.

Authors:  Alexander L Carlson; Kai Xia; M Andrea Azcarate-Peril; Barbara D Goldman; Mihye Ahn; Martin A Styner; Amanda L Thompson; Xiujuan Geng; John H Gilmore; Rebecca C Knickmeyer
Journal:  Biol Psychiatry       Date:  2017-06-27       Impact factor: 13.382

Review 5.  The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood.

Authors:  John Slattery; Derrick F MacFabe; Richard E Frye
Journal:  Clin Med Insights Pediatr       Date:  2016-10-09

6.  Characterization of Microbiota in Children with Chronic Functional Constipation.

Authors:  Tim G J de Meij; Evelien F J de Groot; Anat Eck; Andries E Budding; C M Frank Kneepkens; Marc A Benninga; Adriaan A van Bodegraven; Paul H M Savelkoul
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

7.  The gut microbiota as a modulator of innate immunity during melioidosis.

Authors:  Jacqueline M Lankelma; Emma Birnie; Tassili A F Weehuizen; Brendon P Scicluna; Clara Belzer; Riekelt H Houtkooper; Joris J T H Roelofs; Alex F de Vos; Tom van der Poll; Andries E Budding; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2017-04-19

8.  Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.

Authors:  Jessica R Galloway-Peña; Daniel P Smith; Pranoti Sahasrabhojane; W Duncan Wadsworth; Bryan M Fellman; Nadim J Ajami; Elizabeth J Shpall; Naval Daver; Michele Guindani; Joseph F Petrosino; Dimitrios P Kontoyiannis; Samuel A Shelburne
Journal:  Genome Med       Date:  2017-02-28       Impact factor: 11.117

9.  Interpretation of microbiota-based diagnostics by explaining individual classifier decisions.

Authors:  A Eck; L M Zintgraf; E F J de Groot; T G J de Meij; T S Cohen; P H M Savelkoul; M Welling; A E Budding
Journal:  BMC Bioinformatics       Date:  2017-10-04       Impact factor: 3.169

10.  Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.

Authors:  T G J de Meij; E F J de Groot; C F W Peeters; N K H de Boer; C M F Kneepkens; A Eck; M A Benninga; P H M Savelkoul; A A van Bodegraven; A E Budding
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.